Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018


April 25, 2012
137 Pages - SKU: GBDT3871754
License type:
Table of Contents Search inside this report Related Reports Detailed Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 GlobalData Report Guidance
3 Immunochemistry Overview
3.1 Immunochemistry, Market Segmentation
3.1.1 Anemia/Vitamin Tests
3.1.2 Disease Specific Immunochemistry
3.1.3 Drugs of Abuse/Toxicology
3.1.4 Therapeutic Drug Monitoring (TDM)
3.1.5 Endocrinology Tests
3.1.6 Immunochemistry Analyzers
3.1.7 Immunochemistry Rapid Tests
3.1.8 Organ Function Assays
3.1.9 Specific Proteins
4 Immunochemistry - Global Market Characterization
4.1 Immunochemistry Market, Global, Revenue ($m), Historic, 2004 - 2011
4.2 Immunochemistry Market, Global, Revenue ($m), Forecast, 2011 - 2018
4.3 Immunochemistry Market, Key Trends
4.3.1 Improvement in Software, Hardware Technology and User Interface to Improve Immunochemistry Analyzers Adoption Rate
4.3.2 Advent of Home Based Testing Methods to Lead to Increase in Demand for Diagnostic Testing
4.3.3 Point of Care Testing (POCT) to be in High Demand but Adoption will Depend on Technological Developments in this Field
4.4 Immunochemistry, Market Dynamics
4.4.1 Market Drivers
4.4.2 Market Restraints
5 Global Immunochemistry Market - Analysis by Segment
5.1 Anemia/ Vitamin Test Market, Global, Revenue ($m), Historic, 2004 - 2011
5.2 Anemia/ Vitamin Test Market, Global, Revenue ($m), Forecast, 2011 - 2018
5.3 Anemia/ Vitamin Test Market, Market Dynamics
5.3.1 Market Drivers
5.3.2 Market Restraint
5.4 Disease Specific Immunochemistry Market, Global, Revenue ($m), Historic, 2004 - 2011
5.5 Disease Specific Immunochemistry Market, Global, Revenue ($m), Forecast, 2011 - 2018
5.6 Disease Specific Immunochemistry, Market Dynamics
5.6.1 Market Drivers
5.6.2 Market Restraints
5.7 Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Historic, 2004 - 2011
5.8 Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Forecast, 2011 - 2018
5.9 Drugs of Abuse/Toxicology, Market Dynamics
5.9.1 Market Drivers
5.9.2 Market Restraints
5.10 Therapeutic Drug Monitoring Market, Global, Revenue ($m), Historic, 2004 - 2011
5.11 Therapeutic Drug Monitoring Market, Global, Revenue ($m), Forecast, 2011 - 2018
5.12 Therapeutic Drug Monitoring, Market Dynamics
5.12.1 Market Driver
5.12.2 Market Restraint
5.13 Endocrinology Tests Market, Global, Revenue ($m), Historic, 2004 - 2011
5.14 Endocrinology Tests Market, Global, Revenue ($m), Forecast, 2011 - 2018
5.15 Endocrinology Tests, Market Dynamics
5.15.1 Market Driver
5.15.2 Market Restraint
5.16 Immunochemistry Analyzers Market, Global, Revenue ($m), Historic, 2004 - 2011
5.17 Immunochemistry Analyzers Market, Global, Revenue ($m), Forecast, 2011 - 2018
5.18 Immunochemistry Analyzers, Market Dynamics
5.18.1 Market Driver
5.18.2 Market Restraint
5.19 Immunochemistry Rapid Tests Market, Global, Revenue ($m), Historic, 2004-2011
5.20 Immunochemistry Rapid Tests Market, Global, Revenue ($m), Forecast, 2011-2018
5.21 Immunochemistry Rapid Tests, Market Dynamics
5.21.1 Market Driver
5.21.2 Market Restraint
5.22 Organ Function Assays Market, Global, Revenue ($m), Historic, 2004-2011
5.23 Organ Function Assays Market, Global, Revenue ($m), Forecast, 2011-2018
5.24 Organ Function Assays, Market Dynamics
5.24.1 Market Driver
5.24.2 Market Restraint
5.25 Specific Proteins Market, Global, Revenue ($m), Historic, 2004-2011
5.26 Specific Proteins Market, Global, Revenue ($m), Forecast, 2011-2018
5.27 Specific Proteins, Market Dynamics
5.27.1 Market Driver
5.27.2 Market Restraint
6 Immunochemistry Market, Analysis by Country, Revenue ($m), 2004 - 2018
6.1 Immunochemistry Market, the US, Revenue ($m), Historic, 2004-2011
6.2 Immunochemistry Market, the US, Revenue ($m), Forecast, 2011-2018
6.3 Immunochemistry Market, Canada, Revenue ($m), Historic, 2004-2011
6.4 Immunochemistry Market, Canada, Revenue ($m), Forecast, 2011-2018
6.5 Immunochemistry Market, the UK, Revenue ($m), Historic, 2004-2011
6.6 Immunochemistry Market, the UK, Revenue ($m), Forecast, 2011-2018
6.7 Immunochemistry Market, Germany, Revenue ($m), Historic, 2004-2011
6.8 Immunochemistry Market, Germany, Revenue ($m), Forecast, 2011-2018
6.9 Immunochemistry Market, France, Revenue ($m), Historic, 2004-2011
6.10 Immunochemistry Market, France, Revenue ($m), Forecast, 2011-2018
6.11 Immunochemistry Market, Italy, Revenue ($m), Historic, 2004-2011
6.12 Immunochemistry Market, Italy, Revenue ($m), Forecast, 2011-2018
6.13 Immunochemistry Market, Spain, Revenue ($m), Historic, 2004-2011
6.14 Immunochemistry Market, Spain, Revenue ($m), Forecast, 2011-2018
6.15 Immunochemistry Market, Japan, Revenue ($m), Historic, 2004-2011
6.16 Immunochemistry Market, Japan, Revenue ($m), Forecast, 2011-2018
6.17 Immunochemistry Market, China, Revenue ($m), Historic, 2004-2011
6.18 Immunochemistry Market, China, Revenue ($m), Forecast, 2011-2018
6.19 Immunochemistry Market, India, Revenue ($m), Historic, 2004-2011
6.20 Immunochemistry Market, India, Revenue ($m), Forecast, 2011-2018
6.21 Immunochemistry Market, Australia, Revenue ($m), Historic, 2004-2011
6.22 Immunochemistry Market, Australia, Revenue ($m), Forecast, 2011-2018
6.23 Immunochemistry Market, Brazil, Revenue ($m), Historic, 2004-2011
6.24 Immunochemistry Market, Brazil, Revenue ($m), Forecast, 2011-2018
7 Immunochemistry Market - Strategic Competitive Assessment
7.1 Immunochemistry, Key Market Participants
7.1.1 Siemens Healthcare Inc.
7.1.2 F. Hoffmann-La Roche Ltd.
7.1.3 Abbott Laboratories
8 Immunochemistry - Strategic Pipeline Assessment
9 Immunochemistry Market - Strategic Deals Analysis
9.1 High Number of Partnerships Characterizing the Deal Landscape
9.2 Investments by PE/VC Firms to Spur Innovation in Immunochemistry Market
9.3 Key Deals
9.3.1 Ventana Medical Enters into a Number of Companion Diagnostics Partnerships with Multiple Partners
9.3.2 Dako Enters into Co-development Agreement with Amgen
9.3.3 Sigma-Aldrich Completes Acquisition of BioReliance for $350m
9.3.4 Pronota Raises $4.8m in Series C Financing
9.3.5 Roche Enters into Joint Venture Agreement with Swiss Federal Institute of Technology, University of Zurich and University Hospital Zurich
9.3.6 Affymetrix to acquire eBioscience for $330m
10 Appendix
10.1 Market Definitions
10.1.1 Immunochemistry
10.2 Acronyms
10.3 Research Methodology
10.3.1 Secondary Research
10.3.2 Primary Research
10.3.3 Models
10.3.4 Forecasts
10.3.5 Expert Panels
10.3.6 GlobalData Consulting
10.3.7 Contact Us
10.3.8 Disclaimer
10.4 Sources
10.4.1 Corporate, Industry and Government Sources
10.4.2 Journals
10.4.3 Online Publications
10.4.4 Press Releases
1.1 List of Tables
Table 1: Immunochemistry Market, Global, Revenue ($m), 2004 - 2011
Table 2: Immunochemistry Market, Global, Revenue ($m), 2011 - 2018
Table 3: Companion Diagnostics in Immunochemistry
Table 4: Roche, Number of Companion Diagnostic Projects, 2006-2010
Table 5: Companion Diagnostics, Value Proposition Analysis
Table 6: Companion Diagnostics, Number of Partnerships, 2004-2010
Table 7: Number of Corporate Diagnostic Laboratory Chains, India, 2010
Table 8: Comparison of Various Finance Options
Table 9: Laboratory Acquisitions, the US, 2002-2008
Table 10: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2004 - 2011
Table 11: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2011 - 2018
Table 12: Percentage of Factors Contributing to Anemia Prevalence
Table 13: Correlation of Anemia and Economic Conditions
Table 14: Vitamin D Diagnosis, Product Approvals, 1999-2011
Table 15: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2004 - 2011
Table 16: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2011 - 2018
Table 17: Newly Discovered Tumor Markers, 2008-2011
Table 18: Principle of Action, Tumor Markers
Table 19: Prevalence Rate of Various Allergies, the US, 2001-2010
Table 20: Prevalence of Respiratory Symptoms and Risk Factors Among Children Aged between 6-11 Years, the UK, 2007-2008
Table 21: Prevalence of Autoimmune Diseases, Global, 2010
Table 22: Autoimmune Disease Research Funding, the US, 2005-2011
Table 23: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2004 - 2011
Table 24: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2011 - 2018
Table 25: Past Month* Illicit Drug Usage among Persons Aged 12 and Older, 2010
Table 26: Past Month* Usage of Selected Illicit Drugs among Persons Aged 12 or Older, 2002-2010
Table 27: Past Month* Illicit Drug Use among Persons Aged 12 or Older (%), by Age, 2009 - 2010
Table 28: Drug Tests, Olympics (Summer and Winter), 2000-2010
Table 29: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2004 - 2011
Table 30: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2011 - 2018
Table 31: Number of Public Hospitals with Internet Access, Ecuador, 2008-2010
Table 32: Endocrinology Tests Market, Global, Revenue ($m), 2004 - 2011
Table 33: Endocrinology Tests Market, Global, Revenue ($m), 2011 - 2018
Table 34: Immunochemistry Analyzers Market, Global, Revenue ($m), 2004 - 2011
Table 35: Immunochemistry Analyzers Market, Global, Revenue ($m), 2011 - 2018
Table 36: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
Table 37: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
Table 38: Use of Immunoassay Detection Test, by Diagnosed Disease
Table 39: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
Table 40: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
Table 41: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
Table 42: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
Table 43: Immunochemistry Market, the US, Revenue ($m), 2004-2011
Table 44: Immunochemistry Market, the US, Revenue ($m), 2011-2018
Table 45: Immunochemistry Market, Canada, Revenue($m), 2004-2011
Table 46: Immunochemistry Market, Canada, Revenue ($m), 2011-2018
Table 47: Immunochemistry Market, the UK, Revenue ($m), 2004-2011
Table 48: Immunochemistry Market, the UK, Revenue ($’000), 2011-2018
Table 49: Immunochemistry Market, Germany, Revenue ($m), 2004-2011
Table 50: Immunochemistry Market, Germany, Revenue ($m), 2011-2018
Table 51: Immunochemistry Market, France, Revenue ($m), 2004-2011
Table 52: Immunochemistry Market, France, Revenue ($m), 2011-2018
Table 53: Immunochemistry Market, Italy, Revenue ($m), 2004-2011
Table 54: Immunochemistry Market, Italy, Revenue ($m), 2011-2018
Table 55: Immunochemistry Market, Spain, Revenue ($), 2004-2011
Table 56: Immunochemistry Market, Spain, Revenue ($m), 2011-2018
Table 57: Immunochemistry Market, Japan, Revenue ($m), 2004-2011
Table 58: Immunochemistry Market, Japan, Revenue ($’000), 2011-2018
Table 59: Immunochemistry Market, China, Revenue ($m), 2004-2011
Table 60: Immunochemistry Market, China, Revenue ($m), 2011-2018
Table 61: Immunochemistry Market, India, Revenue ($m), 2004-2011
Table 62: Immunochemistry Market, India, Revenue ($m), 2011-2018
Table 63: Immunochemistry Market, Australia, Revenue ($m), 2004-2011
Table 64: Immunochemistry Market, Australia, Revenue ($m), 2011-2018
Table 65: Immunochemistry Market, Brazil, Revenue ($m), 2004-2011
Table 66: Immunochemistry Market, Brazil, Revenue ($m), 2011-2018
Table 67: Immunochemistry Market, Global, Company Share (%), 2011
Table 68: Siemens Healthcare, Immunochemistry Portfolio*, 2011
Table 69: Siemens Healthcare, Immunochemistry Pipeline Portfolio, by Segment
Table 70: Siemens Healthcare, Emerging Markets Growth, 2008-2010
Table 71: F. Hoffmann-La Roche Ltd., Immunochemistry Portfolio*, 2011
Table 72: F. Hoffmann-La Roche Ltd., Immunochemistry Pipeline Portfolio, by Segment
Table 73: F. Hoffmann-La Roche Ltd., Number of Companion Diagnostic Projects, 2006-2010
Table 74: Abbott Laboratories, Immunochemistry Portfolio*, 2011
Table 75: Abbott Laboratories, Immunochemistry Pipeline Portfolio, by Segment
Table 76: Immunochemistry, Global Pipeline Products, 2011
Table 77: Immunochemistry, Global Pipeline Distribution, by Market Segments, 2011
Table 78: Immunochemistry Market, Deals, 2009-2011
1.2 List of Figures
Figure 1: Immunochemistry, Market Segmentation
Figure 2: Disease Specific Immunochemistry, Market Segmentation
Figure 3: Drugs of Abuse/Toxicology, Market Segmentation
Figure 4: Therapeutic Drug Monitoring, Market Segmentation
Figure 5: Endocrinology Tests, Market Segmentation
Figure 6: Immunochemistry Analyzers, Market Segmentation
Figure 7: Immunochemistry Market, Global, Revenue ($m), 2004 - 2011
Figure 8: Immunochemistry Market, Global, Revenue ($m), 2011 - 2018
Figure 9: Immunochemistry, Market Dynamics
Figure 10: Roche, Number of Companion Diagnostic Projects, 2006-2010
Figure 11: Companion Diagnostics, Value Proposition Analysis
Figure 12: Companion Diagnostics, Number of Partnerships, 2004-2010
Figure 13: Hub and Spoke Model used by Diagnostic Laboratories
Figure 14: Laboratory Acquisitions, the US, 2002-2008
Figure 15: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2004 - 2011
Figure 16: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2011 - 2018
Figure 17: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2004 - 2011
Figure 18: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2011 - 2018
Figure 19: Autoimmune Disease Research Funding, the US, 2005-2011
Figure 20: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2004 - 2011
Figure 21: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2011 - 2018
Figure 22: Past Month* Illicit Drug Usage among Persons Aged 12 and Older, 2010
Figure 23: Past Month* Usage of Selected Illicit Drugs among Persons Aged 12 or Older, 2002-2010
Figure 24: Past Month* Illicit Drug Use among Persons Aged 12 or Older (%), by Age, 2009 - 2010
Figure 25: Drug Tests, Olympics (Summer and Winter), 2000-2010
Figure 26: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2004 - 2011
Figure 27: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2011 - 2018
Figure 28: Number of Public Hospitals with Internet Access, Ecuador, 2008-2010
Figure 29: Endocrinology Tests Market, Global, Revenue ($m), 2004 - 2011
Figure 30: Endocrinology Tests Market, Global, Revenue ($m), 2011 - 2018
Figure 31: Immunochemistry Analyzers Market, Global, Revenue ($m), 2004 - 2011
Figure 32: Immunochemistry Analyzers Market, Global, Revenue ($m), 2011 - 2018
Figure 33: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
Figure 34: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
Figure 35: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
Figure 36: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
Figure 37: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
Figure 38: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
Figure 39: Immunochemistry Market, the US, Revenue ($m), 2004-2011
Figure 40: Immunochemistry Market, the US, Revenue ($m), 2011-2018
Figure 41: Immunochemistry Market, Canada, Revenue($m), 2004-2011
Figure 42: Immunochemistry Market, Canada, Revenue ($m), 2011-2018
Figure 43: Immunochemistry Market, the UK, Revenue ($m), 2004-2011
Figure 44: Immunochemistry Market, the UK, Revenue ($m), 2011-2018
Figure 45: Immunochemistry Market, Germany, Revenue ($m), 2004-2011
Figure 46: Immunochemistry Market, Germany, Revenue ($m), 2011-2018
Figure 47: Immunochemistry Market, France, Revenue ($m), 2004-2011
Figure 48: Immunochemistry Market, France, Revenue ($m), 2011-2018
Figure 49: Immunochemistry Market, Italy, Revenue ($m), 2004-2011
Figure 50: Immunochemistry Market, Italy, Revenue ($m), 2011-2018
Figure 51: Immunochemistry Market, Spain, Revenue ($m), 2004-2011
Figure 52: Immunochemistry Market, Spain, Revenue ($m), 2011-2018
Figure 53: Immunochemistry Market, Japan, Revenue ($m), 2004-2011
Figure 54: Immunochemistry Market, Japan, Revenue ($m), 2011-2018
Figure 55: Immunochemistry Market, China, Revenue ($m), 2004-2011
Figure 56: Immunochemistry Market, China, Revenue ($m), 2011-2018
Figure 57: Immunochemistry Market, India, Revenue ($m), 2004-2011
Figure 58: Immunochemistry Market, India, Revenue ($m), 2011-2018
Figure 59: Immunochemistry Market, Australia, Revenue ($m), 2004-2011
Figure 60: Immunochemistry Market, Australia, Revenue ($m), 2011-2018
Figure 61: Immunochemistry Market, Brazil, Revenue ($m), 2004-2011
Figure 62: Immunochemistry Market, Brazil, Revenue ($m), 2011-2018
Figure 63: Immunochemistry Market, Global, Company Share (%), 2011
Figure 64: Siemens Healthcare, Immunochemistry Pipeline Portfolio, by Segment
Figure 65: Siemens Healthcare, SWOT Analysis, 2011
Figure 66: Siemens Healthcare, Revenue Share, by Region, 2010
Figure 67: Siemens Healthcare, Emerging Markets Growth, 2008-2010
Figure 68: F. Hoffmann-La Roche Ltd., Immunochemistry Pipeline Portfolio, by Segment
Figure 69: F. Hoffmann-La Roche Ltd., SWOT Analysis, 2011
Figure 70: F. Hoffmann-La Roche Ltd., Number of Companion Diagnostic Projects, 2006-2010
Figure 71: Abbott Laboratories, Immunochemistry Pipeline Portfolio, by Segment
Figure 72: Abbott Laboratories, SWOT Analysis, 2011
Figure 73: Immunochemistry, Global Pipeline Products, 2011
Figure 74: Immunochemistry, Global Pipeline Distribution, by Market Segments, 2011
Figure 75: Immunochemistry Market, Deals, 2009-2011
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

General In Vitro Diagnostics Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!